297 related articles for article (PubMed ID: 12447553)
21. Pancreatic cystic neoplasm.
Roggin KK; Chennat J; Oto A; Noffsinger A; Briggs A; Matthews JB
Curr Probl Surg; 2010 Jun; 47(6):459-510. PubMed ID: 20451023
[No Abstract] [Full Text] [Related]
22. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract][Full Text] [Related]
23. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas.
Hammel P; Levy P; Voitot H; Levy M; Vilgrain V; Zins M; Flejou JF; Molas G; Ruszniewski P; Bernades P
Gastroenterology; 1995 Apr; 108(4):1230-5. PubMed ID: 7535275
[TBL] [Abstract][Full Text] [Related]
24. Incidental detection of cystic neoplasms of the pancreas.
Gorin AD; Sackier JM
Md Med J; 1997 Feb; 46(2):79-82. PubMed ID: 9029906
[TBL] [Abstract][Full Text] [Related]
25. [Cystic neoplasms of the pancreas: surgical therapy and chances for cure].
Schmidt-Rohlfing B; Siech M; Mattfeldt T; Schoenberg MH; Beger HG
Z Gastroenterol; 1998 Nov; 36(11):939-45. PubMed ID: 9880820
[TBL] [Abstract][Full Text] [Related]
26. Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms.
Nagashio Y; Hijioka S; Mizuno N; Hara K; Imaoka H; Bhatia V; Niwa Y; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Yamao K
Pancreatology; 2014; 14(6):503-9. PubMed ID: 25458668
[TBL] [Abstract][Full Text] [Related]
27. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic cystadenoma and cystadenocarcinoma: diagnostic value of preoperative morphological investigations.
de Calan L; Levard H; Hennet H; Fingerhut A
Eur J Surg; 1995 Jan; 161(1):35-40. PubMed ID: 7727604
[TBL] [Abstract][Full Text] [Related]
29. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.
van der Waaij LA; van Dullemen HM; Porte RJ
Gastrointest Endosc; 2005 Sep; 62(3):383-9. PubMed ID: 16111956
[TBL] [Abstract][Full Text] [Related]
30. [Mucinous cystic liver tumors: diagnosis and surgical treatment].
Usyaky PV; Kubyshkin VA; Vishnevsky VA; Kovalenko YA; Karel'skaya NA; Kalinin DV; Demidova VS; Varlamov AV
Khirurgiia (Mosk); 2016; (10):27-40. PubMed ID: 27804932
[TBL] [Abstract][Full Text] [Related]
31. Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma.
Wu H; Yan LN; Cheng NS; Zhang YG; Ker CG
Hepatogastroenterology; 2007; 54(79):1915-8. PubMed ID: 18251127
[TBL] [Abstract][Full Text] [Related]
32. [Cystic neoplasms of the pancreas: a review of the literature apropos 5 cases].
Díaz de Liaño Argüelles A; Aizcorbe Garralda M; Ciga Lozano MA; Trujillo Ascanio R; Cobo Huici F; Oteiza Martínez F
Rev Clin Esp; 1999 May; 199(5):288-93. PubMed ID: 10396150
[TBL] [Abstract][Full Text] [Related]
33. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
34. [Macrocystic serous cystadenoma of the pancreas masquerading as a mucinous cystadenoma: case report].
Morales-Oyarvide V; Guzmán-Huerta EA
Cir Cir; 2012; 80(3):278-82. PubMed ID: 23415209
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis of cystadenomas and cystadenocarcinomas of the pancreas. Study of 35 cases].
Lévy M; Lévy P; Hammel P; Zins M; Vilgrain V; Amouyal G; Amouyal P; Molas G; Flejou JF; Voitot H
Gastroenterol Clin Biol; 1995 Feb; 19(2):189-96. PubMed ID: 7750709
[TBL] [Abstract][Full Text] [Related]
36. Macrocystic serous cystadenoma of the pancreas: clinicopathologic features in seven cases.
Sperti C; Pasquali C; Perasole A; Liessi G; Pedrazzoli S
Int J Pancreatol; 2000 Aug; 28(1):1-7. PubMed ID: 11185705
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic and therapeutic implications in two cases of pancreatic cystic tumours: mucinous and serous].
Versaci A; Macrí A; Scuderi G; Ascenti G; Crescenti F; Sfuncia G; Grosso M; Famulari C
G Chir; 2005 Mar; 26(3):83-8. PubMed ID: 15934627
[TBL] [Abstract][Full Text] [Related]
38. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
39. Hand-assisted laparoscopic resection of serous cystadenoma of the pancreas.
Doi R; Ito D; Fujimoto K; Komoto I; Ohta Y; Torii M; Imamura M
Surg Endosc; 2003 Dec; 17(12):2028-31. PubMed ID: 14598159
[TBL] [Abstract][Full Text] [Related]
40. [Management of pancreatic cystic tumors in the Alberto Sabogal Sologuren hospital].
Mori E; Yuen K; Medrano H; Torres J; García C; Montes J
Rev Gastroenterol Peru; 2012; 32(2):169-77. PubMed ID: 23023180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
